Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
07 April 1994Website:
http://acceleratediagnostics.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 28 Jun 2024 21:42:32 GMTDividend
Analysts recommendations
Institutional Ownership
AXDX Latest News
Accelerate Diagnostics (AXDX) lacks the necessary elements for a potential earnings surprise in its upcoming report. Be ready for the expected results.
Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $1.40 per share a year ago.
Accelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results.
Accelerate Diagnostics (AXDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Accelerate Diagnostics (AXDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $2.36 per share versus the Zacks Consensus Estimate of a loss of $1.50. This compares to loss of $2.40 per share a year ago.
Here is how Accelerate Diagnostics (AXDX) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Here is how Accelerate Diagnostics (AXDX) and Cognition Therapeutics, Inc. (CGTX) have performed compared to their sector so far this year.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Laura Pierson - Investor Relations Jack Phillips - President & Chief Executive Officer David Patience - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Operator Good day, and welcome to the Accelerate Diagnostics Incorporated 2023 Q1 Results Conference Call. All participants will be in listen-only mode.
What type of business is Accelerate Diagnostics?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
What sector is Accelerate Diagnostics in?
Accelerate Diagnostics is in the Healthcare sector
What industry is Accelerate Diagnostics in?
Accelerate Diagnostics is in the Medical Devices industry
What country is Accelerate Diagnostics from?
Accelerate Diagnostics is headquartered in United States
When did Accelerate Diagnostics go public?
Accelerate Diagnostics initial public offering (IPO) was on 07 April 1994
What is Accelerate Diagnostics website?
https://acceleratediagnostics.com
Is Accelerate Diagnostics in the S&P 500?
No, Accelerate Diagnostics is not included in the S&P 500 index
Is Accelerate Diagnostics in the NASDAQ 100?
No, Accelerate Diagnostics is not included in the NASDAQ 100 index
Is Accelerate Diagnostics in the Dow Jones?
No, Accelerate Diagnostics is not included in the Dow Jones index
When does Accelerate Diagnostics report earnings?
The next expected earnings date for Accelerate Diagnostics is 09 August 2024